Except for the one that's in there, which is a kind of a composite of what were schedules 2 to 4. What I'm proposing is that the aim is to get a new schedule into Bill C-393, which is a list of drugs approved under CAMR, and that becomes the new schedule 1, and therefore the existing schedule in Bill C-393 becomes schedule 2.
On October 28th, 2010. See this statement in context.